FindMyKOL

Abdul Hakeem, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionRussellville, AR · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2024FindMyKOL type: NationalLatest publicationNot yet indexedOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Abdul Hakeem is a Cardiology physician. ClinicalTrials.gov lists 4 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
    Program year20241 payment
    $63
  • ABIOMED
    Program year20221 payment
    $77
  • Medtronic, Inc.
    Program year20221 payment
    $41
All 5 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    85.9%
    Beta blocker33.9%
    Metoprolol Succinate57%Metoprolol Tartrate19%Carvedilol16%Toprol Xl8%
    Part D<11 patients
    Statin27.3%
    Rosuvastatin Calcium47%Atorvastatin Calcium43%Lipitor10%
    Part D<11 patients

    + 5 more classes in this area

  • Blood & clotting

    14.1%
    P2Y12 inhibitor7.9%
    Clopidogrel65%Brilinta35%
    Part D<11 patients
    Factor Xa inhibitor6.2%
    Eliquis100%
    Part D≥11 patients
Where care is delivered (Part B)78.7% facility · 21.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”